Category: Clinician News
Medical news and evidence summaries for health professionals.
-
Vitamin B6 in listed medicines: TGA consults on label statement and 2 mg warning threshold
TGA consultation (closes 25 November 2026) on a standardised B6 label statement, a stronger neuropathy warning above 2 mg/day and infant restrictions, ahead of Schedule 3 changes from 1 June 2027.
-
TGA extends Estradot and Estraderm MX 100 HRT patch shortage dates: clinician summary
TGA 11 November 2026 update: Estradot 25–100 shortage now to 30 June 2027 and Estraderm MX 100 to 30 November 2026; substitution instrument, PBS and prescribing points.
-
T-REx RCT: resistance training attenuates lean mass loss and preserves strength on tirzepatide — clinician summary
Nature Medicine RCT (n=120, 40 weeks): supervised resistance training with tirzepatide reduced DXA lean soft tissue loss by 1.09 kg and increased strength, with similar weight and fat loss. Methods, harms and limitations.
-
ACSQHC draft virtual care standards: consultation open — Clinicians
National draft virtual-care standards are open for comment until 13 December 2026; intended across primary care and other remote-care settings.
-
Bicillin L-A shortage: supply, alternatives and safety checks — Clinicians
TGA advice on conserving paediatric stock, section 19A alternatives, product-specific preparation and allergen checks during the ongoing shortage.
-
Synedica peptide alert: product uncertainty and Australian primary care — Clinician
TGA laboratory findings highlight unreliable Synedica peptide labels: regulatory advice, primary care relevance and evidence limitations.